Psoriasis Anti-inflammatory Treatment
The project will extensively test a TLR7–specific anti-inflammatory compound, TMX-302, in established animal models of psoriasis. The objective being to acquire the knowledge base needed to proceed on pre-clinical studies and clinical trials for a new effective and safe treatment of psoriasis.
1 374 560.00€
Pharmaceutical Products / Drugs